These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 4320008)
1. The Coronary Drug Project. Initial findings leading to modifications of its research protocol. JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008 [No Abstract] [Full Text] [Related]
2. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847 [No Abstract] [Full Text] [Related]
3. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170 [No Abstract] [Full Text] [Related]
4. The coronary drug project. Design, methods, and baseline results. Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454 [No Abstract] [Full Text] [Related]
5. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin. Stamler J Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823 [No Abstract] [Full Text] [Related]
6. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study. Bhatia ML; Setty KR; Roy SB J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418 [No Abstract] [Full Text] [Related]
7. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
8. Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study. Detre KM; Shaw L Circulation; 1974 Nov; 50(5):998-1005. PubMed ID: 4609636 [No Abstract] [Full Text] [Related]
9. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. Best MM; Duncan CH Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616 [No Abstract] [Full Text] [Related]
10. [Serum lipid-lowering drugs following myocardial infarction]. Schettler G Dtsch Med Wochenschr; 1975 Aug; 100(31):1611-2. PubMed ID: 168052 [No Abstract] [Full Text] [Related]
11. The chemotherapy of hypercholesterolaemia. Heffernan A; Hickey N; Mulcahy R; Fitzgerald O Acta Cardiol; 1969; 24(1):47-55. PubMed ID: 5310563 [No Abstract] [Full Text] [Related]
12. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate. Nordoy A; Rodset JM Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488 [No Abstract] [Full Text] [Related]
13. [Results of the Coronary Drug Project--routine treatment of infarct patients with serum lipid reductants]. Carlson LA; Rössner S Lakartidningen; 1975 Apr; 72(15):1549-51. PubMed ID: 1094207 [No Abstract] [Full Text] [Related]
14. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia]. Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028 [No Abstract] [Full Text] [Related]
15. The Coronary Drug Project: implications for clinical care. Wenger NK; Stamler J Prim Care; 1977 Jun; 4(2):247-53. PubMed ID: 195293 [No Abstract] [Full Text] [Related]